Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs

No abstract is available for this paper.

• Publication year

  1999

• Venue

  International journal of clinical & laboratory research (Print)

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/S005990050060PMID 10356662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of carnitine on valproic acid concentrations in serum, brain, and liver.

  1998cited by this paper
• Asymptomatic Hyperammonemia in Children Treated With Valproic Acid

  1997cited by this paper
• AMMONIA AND CARNITINE CONCENTRATIONS IN CHILDREN TREATED WITH SODIUM VALPROATE COMPARED WITH OTHER ANTICONVULSANT DRUGS

  1991influential reference
• Long‐Term Treatment with Sodium Valproate: Monitoring of Venous Ammonia Concentrations and Adverse Effects

  1987cited by this paper
• Nutritional Influence on Serum Ammonia in Young Patients Receiving Sodium Valproate

  1986cited by this paper
• Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.

  1986cited by this paper
• Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.

  1986cited by this paper
• Effect of associated antiepileptic treatment on valproate-induced hyperammonemia.

  1985cited by this paper
• Chronic valproic acid therapy and incidence of increases in venous plasma ammonia.

  1985influential reference
• Effect of phenothiazines on serum antiepileptic drug concentrations in psychiatric patients with seizure disorder.

  1985cited by this paper
• Increase of valproate‐induced hyperammonemia in normal subjects by carbohydrate intake

  1984cited by this paper
• Valproic acid‐induced hyperammonemia in mentally retarded adults

  1984cited by this paper
• Epilepsy : 100 elementary principles

  1984cited by this paper
• Non‐Dose‐Related Side Effects of Valproate

  1984cited by this paper
• Acute changes of blood ammonia may predict short‐term adverse effects of valproic acid

  1984cited by this paper
• Valproic acid and intractable seizures in severely brain‐damaged patients

  1983cited by this paper
• Sodium Valproate Associated with Phenobarbital: Effects on Ammonia Metabolism in Humans

  1983cited by this paper
• Sodium valproate-induced hyperammonemia in the rat: role of the kidney.

  1983cited by this paper
• [Sodium valproate: a hyperammonemic drug. Study in the epileptic and healthy volunteer].

  1983cited by this paper
• Reye-like syndrome associated with valproic acid.

  1983cited by this paper
• Le valproate de sodium: Une drogue hyperammonemiante: Étude chez l'épileptique et chez le volontaire sain

  1983cited by this paper
• Valproate-induced hyperammonemia in asymptomatic children.

  1983cited by this paper
• Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.

  1982cited by this paper
• Sodium Valproate‐induced hyperammonemia without clinical hepatic dysfunction

  1982cited by this paper
• Carnitine deficiency and hyperammonemia associated with valproic acid therapy.

  1982influential reference
• Valproic acid versus ethosuximide in the treatment of absence seizures

  1982cited by this paper
• Asymptomatic hyperammonemia in patients receiving valproic acid.

  1982cited by this paper
• L'hyperammoniémie isolée. Une conséquence fréquente des traitements par la valproate de sodium.

  1981cited by this paper
• Pharmacology of valproic acid in children with severe epilepsy

  1981cited by this paper
• Hyperammonemia with valproic acid therapy.

  1981influential reference
• [Isolated hyperammonemia. A frequent consequence of treatment with sodium valproate].

  1981cited by this paper
• Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.

  1980cited by this paper
• Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome.

  1980cited by this paper
• Valproate, hyperammonemia, and hyperglycinemia.

  1980cited by this paper
• Treatment of childhood epilepsy with valproic acid

  1980cited by this paper
• Fatal reye‐like syndrome associated with valproic acid

  1980cited by this paper
• Reye-like syndrome associated with valproic acid therapy.

  1979cited by this paper
• An improved and simplified radioisotopic assay for the determination of free and esterified carnitine.

  1976cited by this paper
• A method for the determination of carnitine in the picomole range.

  1972cited by this paper

• Valproic Acid Serum Concentration and Incidence of Toxicity in Pediatric Patients

  2022cites this paper
• Non-pharmacological treatments for pediatric refractory epilepsies

  2022cites this paper
• Risk factors and outcome of hyperammonaemia in people with epilepsy

  2022cites this paper
• Blood Levels of Ammonia and Carnitine in Patients Treated with Valproic Acid: A Meta-analysis

  2022cites this paper
• Glutamate Dehydrogenase as a Promising Target for Hyperinsulinism Hyperammonemia Syndrome Therapy.

  2021cites this paper
• Effects of l-carnitine supplementation in patients with childhood-onset epilepsy prescribed valproate.

  2021cites this paper
• Neuroprotective Effects of Carnitine and Its Potential Application to Ameliorate Neurotoxicity.

  2021cites this paper
• Carnitine supplementation prevents carnitine deficiency caused by pivalate-conjugated antibiotics in patients with epilepsy prescribed valproate.

  2021cites this paper
• Hyperammonemia in Patients With Status Epilepticus Treated With or Without Valproic Acid

  2021cites this paper
• The correlation between carbamazepine and valproic acid monotherapy with serum adiponectin and carnitine

  2020cites this paper
• Association Between Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder.

  2020cites this paper
• Incidence, Presentation and Risk Factors for Sodium Valproate-Associated Hyperammonemia in Neurosurgical Patients: A Prospective Observational Study.

  2020cites this paper
• Effects of levetiracetam and valproic acid treatment on liver function tests, plasma free carnitine and lipid peroxidation in childhood epilepsies.

  2019cites this paper
• Outcome measures in pediatric polypharmacy research: a scoping review

  2019cites this paper
• Serum carnitine levels of children with epilepsy: Related factors including valproate.

  2019cites this paper
• The inhibitory effect of antiretroviral drugs on the L‐carnitine uptake in human placenta

  2019cites this paper
• Nutritional status, macro- and micronutrient deficiency in children with neurodevelopmental disorders

  2018cites this paper
• Clinical Relevance and Cost-Savings of Levocarnitine Versus Ammonul in the Management Of Hyperammonemia in a Cancer Patient: The Impact of a Clinical Pharmacist.

  2018cites this paper
• Evaluation ofserum free carnitine/acylcarnitine levels and left ventricular systolic functions in children with idiopathic epilepsy receiving valproic acid.

  2018cites this paper
• Adverse Effects of Treatment with Valproic Acid during the Neonatal Period

  2018cites this paper
• Changing incidence of hyperammonemia in Japan from 2006 to 2013: expansion of new antiepileptic drugs reduces the risk of hyperammonemia

  2015cites this paper
• Carnitine deficiency: Risk factors and incidence in children with epilepsy.

  2015cites this paper
• Dietary Intakes and Nutritional Issues in Neurologically Impaired Children

  2015cites this paper
• Role of some nutritional complements and biological supplements in the management of epilepsy

  2015cites this paper
• Hyperammonemia-induced encephalopathy: A rare devastating complication of bariatric surgery.

  2015cites this paper
• Effects of Drug Transporters on Pharmacological Responses and Safety.

  2015cites this paper
• Trace Elements, Antioxidant Enzymes and Free Carnitine Levels Among Epileptic Patients Treated with Valproate Monotherapy

  2014cites this paper
• Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).

  2014cites this paper
• Role of various vitamins in the patients with epilepsy

  2013cites this paper
• Role of certain nutritional supplements and biological regulators in the epilepsy

  2013cites this paper
• Histological study of hippocampal cortex after long-term valproate admininistration to rats

  2013cites this paper
• Hyperammonemia induced by interaction of valproate and quetiapine.

  2013cites this paper
• Risk factors for hyperammonemia in pediatric patients with epilepsy

  2013cites this paper
• Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients.

  2012cites this paper
• Plasma carnitine levels in children with idiopathic epilepsy treated with old and new antiepileptic drugs

  2012cites this paper
• Correlation between plasma ammonia level and serum trough concentration of free valproic acid in patients with epilepsy.

  2012cites this paper
• Carnitine, nutritional supplementation and discontinuation of ketogenic diet therapies.

  2012cites this paper
• Valproate associated hyperammonemic encephalopathy

  2011cites this paper
• Influences of bone and mineral metabolism in epilepsy

  2011cites this paper
• The real mechanism of VPA-induced hyperammonemia remains unknown.

  2011cites this paper
• Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.

  2011cites this paper
• Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: Modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States

  2011cites this paper
• New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA.

  2011cites this paper
• Valproate-induced worsening of seizures in an infant

  2011cites this paper
• Blood Ammonia Levels in Epileptic Children on 2 Dose Ranges of Valproic Acid Monotherapy: A Cross-Sectional Study

  2011cites this paper
• Valproat tedavisi ile nöbetleri sıklaşan sütçocuğu: tanısal bir ipucu

  2011cites this paper
• Drugs and pharmaceuticals: management of intoxication and antidotes

  2010cites this paper
• A novel explanation for potential toxic effects of valproic acid on creatine: implications for autism.

  2010cites this paper
• Valproic acid-induced encephalopathy in very long course treated patients

  2009cites this paper
• [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].

  2009cites this paper
• Risk Factors for Hyperammonemia due to Valproic Acid in Patients with Epilepsy: A Case-control Study

  2009cites this paper
• The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.

  2009cites this paper
• Hyperammonemic Encephalopathy Caused by Carnitine Deficiency

  2008cites this paper
• Postictal transient hyperammonemia.

  2008cites this paper
• Use of this content is subject to the Terms and Conditions Hyperammonemia in the ICU Chest

  2008cites this paper
• Vigabatrin, lamotrigine, topiramate and serum carnitine levels.

  2008cites this paper
• The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?

  2008influential citation
• Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania.

  2007cites this paper
• Effects of Valproate on Acylcarnitines in Children with Epilepsy Using ESI‐MS/MS

  2007cites this paper
• Natural approaches to epilepsy.

  2007cites this paper
• Old and new antiepileptic drugs for the treatment of idiopathic generalized epilepsies.

  2007cites this paper
• Non‐convulsive status epilepticus secondary to valproic acid‐induced hyperammonemic encephalopathy

  2007cites this paper
• Case files of the Children’s Hospital of Michigan Regional Poison Control Center: The use of carnitine for the management of acute valproic acid toxicity

  2007cites this paper
• Hyperammonemia in the ICU.

  2007cites this paper
• Valproat-assoziierte Enzephalopathie - 19 neue Fälle in Deutschland zwischen 1994 und 2003 - eine Nebenwirkung nicht nur bei jüngeren Kindern

  2007cites this paper
• Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.

  2006cites this paper
• Propofol for sedation in neuro-intensive care

  2006cites this paper
• Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.

  2006cites this paper
• Valproate as a Mainstay of Therapy for Pediatric Epilepsy

  2006cites this paper
• Troubles cognitifs, syndrome extrapyramidal et hyperammoniémie sous traitement thymorégulateur par divalproate de sodium : à propos d’un cas

  2005cites this paper
• L-carnitine was safely administered in the setting of valproate toxicity.

  2005cites this paper
• Encephalopathy and Hyperammonemia Associated with Valproic Acid

  2005cites this paper
• The Nordic Expert Group for Criteria Documentation of Health Risks from Chemicals 137. Ammonia

  2005cites this paper
• Novel Organic Cation Transporter 2-Mediated Carnitine Uptake in Placental Choriocarcinoma (BeWo) Cells

  2005cites this paper
• [A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder].

  2005cites this paper
• Endocrine and Metabolic Changes in Epileptic Patients Receiving Valproic Acid

  2005cites this paper
• Valproate-induced hyperammonemic encephalopathy.

  2004cites this paper
• Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam

  2004cites this paper
• L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2.

  2004cites this paper
• Serum Carnitine Levels During Oxcarbazepine and Carbamazepine Monotherapies in Children With Epilepsy

  2003cites this paper
• Carnitine level in Chinese epileptic patients taking sodium valproate.

  2003influential citation
• Expression and localization of organic cation / carnitine transporter OCTN 2 in Caco-2 cells

  2003cites this paper
• Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells.

  2003cites this paper
• Valproic Acid-Induced Hyperammonemic Encephalopathy

  2002cites this paper
• Valproate-induced hyperammonaemia.

  2002cites this paper
• Valproate-Induced Hyperammonemic Encephalopathy

  2002influential citation
• Serum and CSF Glutamine Levels in Valproate‐related Hyperammonemic Encephalopathy

  2002influential citation
• Deepening coma in an epileptic patient: the missing link to the urea cycle. Hyperammonaemic metabolic encephalopathy.

  2002cites this paper
• Deepening coma in an epileptic patient: the missing link to the urea cycle

  2002cites this paper